Palisade Capital Management’s Celgene Corp CELG Stock Holding History

Palisade Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,340	Closed	-$406K	–	469
2018 Q4	$406K	Sell	6,340 -1,090	-15%	-$80.5K	0.01%	388
2018 Q3	$665K	Buy	7,430 +200	+3%	+$17.7K	0.02%	383
2018 Q2	$574K	Hold	7,230	–	–	0.02%	380
2018 Q1	$645K	Sell	7,230 -645	-8%	-$61.9K	0.02%	366
2017 Q4	$822K	Buy	7,875 +5,865	+292%	+$662K	0.03%	342
2017 Q3	$293K	Buy	+2,010	New	+$274K	0.01%	391
2016 Q2	–	Sell	-2,000	Closed	-$200K	–	582
2016 Q1	$200K	Buy	+2,000	New	+$206K	0.01%	519

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Palisade Capital Management's CELG Position: Q1 2019 in Review

Palisade Capital Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 6,340 shares — an estimated $406K sold.

Palisade Capital Management first reported a position in CELG in Q1 2016 and held it in 7 quarters. The position peaked at $822K in Q4 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

Palisade Capital Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
Palisade Capital Management sold 6,340 Celgene Corp shares in Q1 2019, an estimated $406K.
Palisade Capital Management first reported a position in Celgene Corp in Q1 2016 and held it in 7 quarters.
Palisade Capital Management's Celgene Corp position peaked at $822K in Q4 2017.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Palisade Capital Management's 13F filing for Q1 2019, filed 13 May 2019.